Skip to main content
Select your language
English
Français
Русский
Español
العربي
Português
User Menu
Log in
Consolidated Guidelines
Operational Handbooks
Training Catalogue
Research and Innovation
Quick Search
Recommendations
Dosage finder
Select your language
English
Français
Русский
Español
العربي
Português
User Menu
Log in
TB KaSPar
Feedback
Breadcrumb
Home
Research and Innovation
Research and Innovation
WHO Evidence Considerations for Vaccine Policy Development for Tuberculosis Vaccines Intended for Adults and Adolescents
Guidance on evidence generation on new regimens for tuberculosis treatment
Target product profiles for tuberculosis diagnosis and detection of drug resistance
Target regimen profiles for tuberculosis treatment
Target product profiles for tests for tuberculosis treatment monitoring and optimization
Global strategy for TB research and innovation
Development of a Target Product Profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease
WHO Preferred Product Characteristics for Therapeutic Vaccines to Improve Tuberculosis Treatment Outcomes
WHO Preferred Product Characteristics for New Tuberculosis Vaccine
Target product profiles for tuberculosis preventive treatment
Pagination
Page 1
Next page
››